Gentex Q4 sales up 19% to $644.4 million; 2025 EPS $1.74 vs $1.76
Gentex reported fourth-quarter 2025 consolidated net sales of $644.4 million, up 19% year over year with the VOXX acquisition included, and diluted EPS of $0.43 versus $0.39. Core Gentex sales were about flat at $541.0 million, while full-year 2025 diluted EPS fell to $1.74 from $1.76 and net income attributable to Gentex declined to $384.8 million from $404.5 million. The company also gave 2026 revenue guidance of $2.60 to $2.70 billion and 2027 revenue guidance of $2.75 to $2.85 billion.
Key points
- Q4 2025 consolidated net sales $644.4 million, up from $541.6 million; core Gentex sales $541.0 million
- Q4 2025 consolidated gross margin 34.8%; core Gentex gross margin 35.5%, up 300 basis points
- Calendar 2025 diluted EPS $1.74 vs $1.76 in 2024; capital returned to shareholders $425.9 million, including $319.0 million in buybacks
- 2026 guidance: revenue $2.60 to $2.70 billion, gross margin 34% to 35%; 2027 revenue guidance $2.75 to $2.85 billion
The filing
Written by AI on Nov 8, 2026, 1:01 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 30, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.